11/14
01:34 pm
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $77.00 price target on the stock.
Medium
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $77.00 price target on the stock.
11/14
08:56 am
capr
Rating for CAPR
Medium
Report
Rating for CAPR
10/9
02:40 pm
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
9/25
08:28 am
capr
Rating for CAPR
Medium
Report
Rating for CAPR
9/25
08:28 am
capr
Rating for CAPR
Medium
Report
Rating for CAPR
9/25
08:15 am
capr
Rating for CAPR
Medium
Report
Rating for CAPR
9/24
11:06 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
High
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
9/23
02:05 pm
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Medium
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
9/23
01:28 pm
capr
Rating for CAPR
High
Report
Rating for CAPR
9/23
01:28 pm
capr
Rating for CAPR
High
Report
Rating for CAPR